Spero Therapeutics to Present at the Jefferies 2018 Healthcare Conference in June

CAMBRIDGE, Mass. , June 01, 2018 (GLOBE NEWSWIRE) — Spero Therapeutics , Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant bacterial infections, announced today that Ankit

READ FULL TEXT

Leave a Reply

Your email address will not be published.